Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.
Verana Health Merges with COTA to Dramatically Expand Scale,…
Continue Reading
What You Should Know:
– Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has announced the merger with COTA Healthcare®.
– The merger expands the company’s therapeutic offerings in…
Continue Reading
The translation of Artificial Intelligence (AI) into clinical practice demands high-quality Real-World Data (RWD), yet unstructured healthcare information poses a significant barrier. To address this, we developed S-RACE, a secure, cloud-based platform designed to…
Continue Reading
Aracelis Torres, PhD, MPH, SVP of Data & Science at Verana Health
In today’s pharmaceutical industry, real-world evidence (RWE) offers significant potential across all phases of the product life cycle, from trial design to product…
Continue Reading
What You Should Know:
– WellSky and uMed have formed a strategic partnership to integrate clinical research opportunities directly into the workflows of home-based care providers. By combining WellSky’s network of 10,000 providers with uMed’s…
Continue Reading
Strategic Partnerships & Collaborations
Oracle Health & Baylor College of Medicine
The partners will leverage Oracle’s AI data platform and Real-World Data (RWD), containing over 120 million patient records, to create one of the nation’s largest…
Continue Reading
What You Should Know:
– Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced that its international oncology research network has tripled in size…
Continue Reading
Real-world data (RWD) from electronic health records and digital health databases present unique opportunities to study causal effects in healthcare. While Difference-in-Differences (DiD) analysis is widely used for such analyses, it can be biased…
Continue Reading
Natalie Schibell, VP of Market Strategy and Communications at Aetion,
Real-world evidence (RWE) has become central to evaluating therapies, medical products, and health interventions—providing insight into how they perform outside controlled clinical trials. As healthcare…
Continue Reading
Viraj Narayanan, CEO at Cornerstone AI
Daniel Lane, Head of RWD Strategy & Operations at Bristol Myers Squibb
Real-world data (RWD) has become the pharmaceutical industry’s most promising yet challenging frontier. While companies have long…
Continue Reading
